Ikigai Ventures Limited is a special purpose acquisition company (SPAC) based in Guernsey. The company completed its Initial Public Offering (IPO) on September 15, 2022, raising £2.09 million by offering 4,180,000 ordinary shares at £0.50 each. Ikigai Ventures is focused on acquiring high-growth businesses in sectors such as healthcare, finance, agriculture, mining, and artificial intelligence. As a SPAC, it has not yet commenced any operations or generated any revenues. Founded on June 23, 2011, under the name C F NICHOL LIMITED, the company rebranded to Ikigai Ventures Limited on June 24, 2016. Its registered office is located at 17-18 Leach Road, Chard Business Park, Chard, Somerset, United Kingdom. As of April 8, 2026, Ikigai Ventures Limited's market capitalization was approximately $11.5 million USD, with an enterprise value of $10.9 million USD. The company reported trailing twelve months (TTM) revenue of -$3.98K USD and a net income of -$915.06K USD. The current CEO is Kane Black, and the company is listed on the London Stock Exchange under the ticker symbol IKIV.
AI-researched from public web sources — may contain errors or omissions and is not a substitute for verifying independently.
Ikigai Ventures Limited's offering is currently announced on AIM.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with Ikigai Ventures Limited.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/ikigai-ventures" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="Ikigai Ventures Limited — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/ikigai-ventures?theme=light as the src instead.
https://www.discoveripo.com/ipo/ikigai-ventures/opengraph-image
Ikigai Ventures Limited IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/ikigai-ventures?utm_source=embed&utm_medium=text&utm_campaign=ikigai-ventures
Get emailed when Ikigai Ventures Limited's terms, price, or expected date change — no weekly noise, just this company.
Ikigai Ventures Limited is listing on AIM.
Ikigai Ventures Limited is a special purpose acquisition company (SPAC) based in Guernsey. The company completed its Initial Public Offering (IPO) on September 15, 2022, raising £2.09 million by offering 4,180,000 ordinary shares at £0.50 each. Ikigai Ventures is focused on acquiring high-growth businesses in sectors such as healthcare, finance, agriculture, mining, and artificial intelligence. As a SPAC, it has not yet commenced any operations or generated any revenues. Founded on June 23, 2011, under the name C F NICHOL LIMITED, the company rebranded to Ikigai Ventures Limited on June 24, 2016. Its registered office is located at 17-18 Leach Road, Chard Business Park, Chard, Somerset, United Kingdom. As of April 8, 2026, Ikigai Ventures Limited's market capitalization was approximately $11.5 million USD, with an enterprise value of $10.9 million USD. The company reported trailing twelve months (TTM) revenue of -$3.98K USD and a net income of -$915.06K USD. The current CEO is Kane Black, and the company is listed on the London Stock Exchange under the ticker symbol IKIV.
The UK Financial Conduct Authority's National Storage Mechanism — an intention-to-float or AIM pre-admission announcement date, not a confirmed first-dealings date. Retrieved Sep 17, 2026.
View the original filing on FCA NSM →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy